Colchicine, the treatment of gout, can it help in the face of the Corona pandemic?
Colchicine and its relationship to coronavirus. Talking about the Coronavirus has become our primary concern lately, as everyone keeps searching for how to confront this global epidemic. From here, the interest of all researchers in the world fell to search for any drug that might have helped reduce the Corona pandemic.
In fact, colchicine is basically one of the most effective drugs for treating gout, but during my research on this drug, I found that some scientists praise its role in facing the Corona virus.
So do colchicine tablets really play a role in combating covid 19 besides their role in treating gout, or are they just speculation !!!!?
This is what we will explain to you, dear reader, through this article
Erythema Nodosum Treatment in Delhi.
Treatments for erythema nodosum include anti-inflammatory drugs and corticosteroids by mouth or local injection.
Physicians sometimes administer colchicine to reduce inflammation.
Erythema nodosum (EN), also known as subacute migratory panniculitis of Vilanova and Piñol, is an inflammatory condition characterized by inflammation of the fat cells under the skin, resulting in tender red nodules or lumps that are usually seen on both shins.
Increasing prevalence of gout and other related disorders, rising public awareness, rise in R investment in various industries, and growing elderly population are key factors contributing to high CAGR of Colchicine Market during forecast period.Colchicine Market Size – USD 553.8 Million in 2018, Market Growth - CAGR of 9.3%, Market Trends – Wider application range of the drugThe newest report compiled by Reports and Data, titled ‘Global Colchicine Market Forecast to 2027,’ serves as an appropriate prototype of the global Colchicine market.
The report endows the reader with a panoramic view of the Colchicine industry, simultaneously offering viable insights into the anticipated market size, revenue share, and sales & distribution networks.
These insights are bound to help readers visualize the key outcomes of this industry in the near future and take necessary measures to stand tall, even during times as challenging as the current COVID-19 crisis.
Venture capitalists and the key businesses involved in this sector are the primary addressees of this report, which is intended to assist them in decision-making and formulating productive business plans.To Get a PDF Sample Copy of the Report, visit @ https://www.reportsanddata.com/sample-enquiry-form/2374In the later segment of this report, our team of market researchers has holistically covered the profound impact of the COVID-19 pandemic on the global Colchicine market.
The outbreak has resulted in several dramatic changes in the current Colchicine business sphere, wreaking a significant financial crunch for the leading vendors and producers in this industry.
The report concludes with vital data and information pertaining to the global market growth on both regional and global levels.Key participants include Abbott Laboratories, Hikma Pharmaceuticals, Cipla Limited, West Ward Pharmaceutical, Takeda Pharmaceuticals America, Inc., Cardinal Health, Major Pharmaceuticals, Excellium Pharmaceutical, Mylan Pharmaceuticals Inc., Odan LaboratoriesFor the purpose of this report, Reports and Data has segmented the colchicine market on the basis of dosage formulation, application, end use and region:Dosage Formulation Outlook (Revenue, USD Million; 2016-2026)TabletCapsuleSolutionCreamInjectionOthersApplication Outlook (Revenue, USD Million; 2016-2026)Acute GoutChronic GoutFamilial Mediterranean FeverGout ProphylaxisActinic KeratosisAmyloidosisBehcet's DiseasePericarditisPseudogoutDermatitis HerpetiformisPaget's DiseaseBiliary and Hepatic CirrhosisOthersEnd Use Outlook (Revenue, USD Million; 2016-2026)PediatricAdultGeriatricScope of the Global Colchicine Market:One of the significant components of the global Colchicine market is the methodical segmentation of the market.
Market OverviewThe Global Gout Therapeutics Market is expected to grow at a high CAGR during the forecasting period (2020-2027).Gout s a type of inflammatory arthritis caused by the overabundance of uric acid in the body which is due to either producing too much or excreting too little.
In chronic gout, hard swellings (known as tophi) can form on the joints which are made of uric acid and grow large, even to the point of breaking through the skin.
Download free sample: https://www.datamintelligence.com/download-sample/gout-therapeutics-market Market DynamicsThe global gout therapeutics market is impacted by several factors such as the rising prevalence of gout globally due to change in lifestyle, increasing alcohol consumption, increasing obesity & kidney diseases, high purine diet, and consumption of several medications such as diuretics.Gout is the most common form of inflammatory arthritis, characterized by painful and disabling acute attacks.
For instance, on June 22nd, 2020, anti-viral drug Favipiravir (Fabiflu) was approved for the treatment of mild to moderate COVID-19 patients will be commercialized full scale in a week, says drugmaker Glenmark Pharmaceuticals.
Febuxostat side effects include rash, nausea, reduced liver function, and an increased risk of heart-related death.
Segment AnalysisBy drug class, the gout therapeutics market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), antihyperuricemic agents (urate-lowering drugs), corticosteroids, colchicine, and others.
